An observational study in Acute Respiratory Distress Syndrome, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-12-04.
Sponsored by Tanta University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Respiratory Distress Syndrome with a site in Egypt — 11 open to participants now, 11 under way, 1 of them phase 3. Respiratory Distress Syndrome · Egypt.
Among the 32 studies in Respiratory Distress Syndrome with a site in Egypt, this one is one of 6 that started in 2024, is one of 9 observational ones, reaches primary completion later than 3 of the 10 other live ones, and was the 18th registered.
1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.
Browse Respiratory Distress Syndrome studies →11 of the 32 studies in Respiratory Distress Syndrome with a site in Egypt are open now. Recruiting first, the newest first:
Ain Shams University · Sites in Egypt
Ages 1 days–1 mo
Tanta University · Sites in Egypt
Ages 28 wk–36 wk
Assiut University · Sites in Egypt
Ages 20–39 · Women only
Tanta University · Sites in Egypt
Ages 22–80
Kafrelsheikh University · Sites in Egypt
Ages 20–35 · Women only · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 3 · Phase 4 2
First in 2007; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 100 across 476 observational studies indexed under Respiratory Distress Syndrome.
Median enrollment 66 across the 23 interventional studies, 60 across the 9 observational. Of the 17 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 32 have an industry lead sponsor. The 10 most frequent:
Tanta University is the lead sponsor of 1,015 studies on the registry; 321 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Tanta University has 6 studies filed under Respiratory Distress Syndrome — fewer than ten, so there is no comparison to draw.
4 of the studies in Respiratory Distress Syndrome with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
| NCT07286409Tanta UniversityNebulized Furosemide, Heparin, Hypertonic Saline in Mechanically Ventilated Acute Respiratory Distress Syndrome Adult Patients | 2026-12 |
| NCT06874478Assiut UniversityRespiratory Distress and Elective Cesarean Section at Term | 2027-05 |
| NCT07926009Ain Shams UniversityNAVA Use in Preterm Neonates With Respiratory Distress Syndrome | 2027-10 |
Add all 4 to your calendar (.ics) → With an account.
Among the 32 studies in Respiratory Distress Syndrome with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Thorathic fluid content measurement using indirect cardiometry is required for prediction of Weaning from mechanical ventilation in cases of acute respiratory distress syndrome and its value in sucsess Weaning
Adult Patient with ARDS on ventilator in our ICU prepared for weaning
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Measurements of thorathic fluid content
Success of weaning from mechanical ventilation
Number of participants without artificial aids for ventilation
Time frame: 48 hours
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Dec 2024, 0 months after the start.
Of 228 non-industry observational studies under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 0 months is below that.
Counting every sponsor, half of 234 studies reached it within 24 months; a quarter within 12 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome →